Barclays
XPER icon

Barclays’s Xperi XPER Stock Holding History

Barclays’s Portfolio XPER Stock Details XPER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.9K Sell
14,632
-68,546
-82% -$397K ﹤0.01% 4109
2025
Q4 		$487K Buy
83,178
+15,128
+22% +$94.9K ﹤0.01% 3861
2025
Q3 		$441K Sell
68,050
-6,227
-8% -$41.1K ﹤0.01% 3891
2025
Q2 		$588K Buy
74,277
+29,225
+65% +$220K ﹤0.01% 3670
2025
Q1 		$348K Sell
45,052
-23,755
-35% -$208K ﹤0.01% 3742
2024
Q4 		$707K Sell
68,807
-1,184
-2% -$11.1K ﹤0.01% 3611
2024
Q3 		$647K Buy
69,991
+46,426
+197% +$382K ﹤0.01% 3617
2024
Q2 		$193K Sell
23,565
-17,643
-43% -$167K ﹤0.01% 3597
2024
Q1 		$497K Sell
41,208
-26,972
-40% -$297K ﹤0.01% 3598
2023
Q4 		$751K Buy
68,180
+25,740
+61% +$248K ﹤0.01% 3633
2023
Q3 		$418K Buy
42,440
+21,163
+99% +$250K ﹤0.01% 2906
2023
Q2 		$280K Sell
21,277
-316
-1% -$3.43K ﹤0.01% 3086
2023
Q1 		$236K Sell
21,593
-154,572
-88% -$1.61M ﹤0.01% 3693
2022
Q4 		$1.52M Buy
+176,165
New +$2.02M ﹤0.01% 2458

Other funds holding XPER

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
I
Immersion Aventura, Florida $145M AUM 17.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays's XPER Position: Q1 2026 in Review

Barclays reduced its Xperi (XPER) stake by 82% in Q1 2026, selling an estimated $397K and leaving 14,632 shares worth $81.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4109.

Barclays first reported a position in XPER in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.52M in Q4 2022. 141 funds tracked by Wall St. Rank hold XPER as of Q1 2026.

  • Barclays held 14,632 shares of Xperi worth $81.9K as of Q1 2026.
  • Barclays sold 68,546 Xperi shares in Q1 2026, an estimated $397K.
  • Xperi made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4109 holding.
  • Barclays first reported a position in Xperi in Q4 2022 and has held it in 14 quarters since.
  • Barclays's Xperi position peaked at $1.52M in Q4 2022.
  • 141 funds tracked by Wall St. Rank held Xperi as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.